Drug Therapy in Cognitive Disorders and Its Effects on Oral Health.

Autor:	Ahmed SE; Prosthodontics, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND.; Oral Medicine, Vinayaka Missions Research Foundation (VMRF) Deemed to be University, Salem, IND., Begum R; Anatomy, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND., Kumar AS; Prosthodontics and Crown and Bridge, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND., M A; Prosthodontics, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND., R V; Prosthodontics, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND., I V; Dentistry, Sri Ramakrishna Dental College and Hospital, Coimbatore, IND.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 Jul 24; Vol. 14 (7), pp. e27194. Date of Electronic Publication: 2022 Jul 24 (Print Publication: 2022).
DOI:	10.7759/cureus.27194
Abstrakt:	Dementia and Alzheimer's disease are the two most characteristic cognitive disorders presenting numerous cognitive dysfunctions such as memory loss, functional impairment, speech impairment, and orientation problems. In India, there is an increased risk in the elderly population leading to the prevalence of Alzheimer's and dementia-related diseases. Therefore, it is not only general health care practitioners but also oral health care providers also play a major role in rehabilitating and treating this type of patient. So, it is necessary for oral health care providers to understand the pharmacologic agents used for the management of Alzheimer's and dementia-related diseases. This article gives an insight into the management of dementia and Alzheimer's disease and also an update on the drug therapies for AD and outlines their implications on oral health. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Ahmed et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu